DEGODE

DEGODE

Degode has recreated a patent-protected prescription drug for the treatment of acne and rosacea (generic drug). It is the first company in the EU to launch this product in co-operation with a well-established pharmaceutical company in initially 10 European countries. The development is completed and the approval phase has begun. Due to a sophisticated formulation which is very close to the original, Degode was able to convince the EU authorities to dispense with the usually long-term and cost-intensive efficacy studies.
This means a significant competitive advantage for Degode. As a result of this unique regulatory study situation, Degode will be the first supplier within the EU

Generics by DEGODE

Generics by DEGODE are in no way inferior to the original.
What are generics?
Generics, exactly like the so-called "biosimilars", are subject to the same quality and efficacy requirements as the preparations of the original manufacturers.
more
DEGODE
Degode has recreated a patent-protected prescription drug for the treatment of acne and rosacea (generic drug). It is the first company in the EU to launch t...
more
Beloren
Beloren contains the active ingredient azelaic acid which has been proving its worth for 20 years in the treatment of acne. This substance has been approved...
more
Crowdfunding für Startups | Companisto

Was sind Generika?

Ein Film des Branchenverbandes ProGenerika

Contact

DEGODE GmbH
Kastanienallee 46
15344 Strausberg
03341 589 9040